相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-Inflammatory Drugs as Anticancer Agents
Silvia Zappavigna et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
Shuangshuang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Inhibition of PI3K-AKT Signaling Blocks PGE2-Induced COX-2 Expression in Lung Adenocarcinoma
Jianjian Yang et al.
ONCOTARGETS AND THERAPY (2020)
PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
Rui Liu et al.
CELL DEATH & DISEASE (2020)
Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
Federica Finetti et al.
BIOLOGY-BASEL (2020)
Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis
Qin-fang Deng et al.
JOURNAL OF CANCER (2020)
The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism
Gerta Hoxhaj et al.
NATURE REVIEWS CANCER (2020)
The Value of COX-2, NF-κB, and Blood Routine Indexes in the Prognosis of Malignant Peritoneal Mesothelioma
Wenjie Yin et al.
ONCOLOGY RESEARCH AND TREATMENT (2019)
p53-Dependent Anti-Proliferative and Pro-Apoptotic Effects of a Gold(I) N-Heterocyclic Carbene (NHC) Complex in Colorectal Cancer Cells
Yasamin Dabiri et al.
FRONTIERS IN ONCOLOGY (2019)
Bergapten induces G1 arrest and pro-apoptotic cascade in colorectal cancer cells associating with p53/p21/PTEN axis
Ching-Pin Lin et al.
ENVIRONMENTAL TOXICOLOGY (2019)
Design of spherically structured 3D in vitro tumor models -Advances and prospects
L. P. Ferreira et al.
ACTA BIOMATERIALIA (2018)
Modulation of reactive oxygen species via ERK and STAT3 dependent signalling are involved in the response of mesothelioma cells to exemestane
Barbara Nuvoli et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
17β-estradiol upregulates IL6 expression through the ERβ pathway to promote lung adenocarcinoma progression
Quanfu Huang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer
Laura P. Stabile et al.
JOURNAL OF THORACIC ONCOLOGY (2018)
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma
Marika Rossini et al.
FRONTIERS IN ONCOLOGY (2018)
Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: Hyaluronate-targeted versus PEGylated protamine nanocapsules for breast cancer therapy
Ahmed O. Elzoghby et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells
Masayuki Yamaji et al.
CANCER MEDICINE (2017)
Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage
Ansar Karimian et al.
DNA REPAIR (2016)
Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models
Barbara Nuvoli et al.
ONCOTARGET (2016)
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Anna C. Bibby et al.
EUROPEAN RESPIRATORY REVIEW (2016)
Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer
Darren Micallef et al.
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION (2016)
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
G. O'Callaghan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales
P. Beckett et al.
LUNG CANCER (2015)
NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species
Rajeshwary Ghosh et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers
Susan B. Brown et al.
STEROIDS (2015)
CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
Barbara Nuvoli et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
Barbara Nuvoli et al.
MOLECULAR CANCER (2014)
Molecular pathogenesis of malignant mesothelioma
Yoshitaka Sekido
CARCINOGENESIS (2013)
Cyclooxygenase-2, Epidermal Growth Factor Receptor, and Aromatase Signaling in Inflammation and Mesothelioma
Barbara Nuvoli et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Multifaceted roles of PGE2 in inflammation and cancer
Masako Nakanishi et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
被撤回的出版物: Increased Levels of COX-2 and Prostaglandin E2 Contribute to Elevated Aromatase Expression in Inflamed Breast Tissue of Obese Women (Publication with Expression of Concern. See vol. 9, pg. 1142, 2019) (Retracted article. See vol. 11, pg. 1306, 2021)
Kotha Subbaramaiah et al.
CANCER DISCOVERY (2012)
An Extracellular Signal-Regulated Kinase 2 Survival Pathway Mediates Resistance of Human Mesothelioma Cells to Asbestos-Induced Injury
Arti Shukla et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Global Magnitude of Reported and Unreported Mesothelioma
Eun-Kee Park et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells
Daniela Stoppoloni et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Apoptosis Induced by Piroxicam plus Cisplatin Combined Treatment Is Triggered by p21 in Mesothelioma
Alfonso Baldi et al.
PLOS ONE (2011)
COX-2 activation is associated with Akt phosphorylation and poor survival in ER-negative, HER2-positive breast cancer
Sharon A. Glynn et al.
BMC CANCER (2010)
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A. Scherpereel et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
Daniela Stoppoloni et al.
MOLECULAR CANCER (2010)
COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines
Sara L. O'Kane et al.
LUNG CANCER (2010)
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer
C. Falandry et al.
ANNALS OF ONCOLOGY (2009)
Expression of the Embryonic Lethal Abnormal Vision-like Protein HuR in Human Mesothelioma Association With Cyclooxygenase-2 and Prognosis
Daniela Stoppoloni et al.
CANCER (2008)
The complex role of estrogens in inflammation
Rainer H. Straub
ENDOCRINE REVIEWS (2007)
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways
Sandra Donnini et al.
FASEB JOURNAL (2007)
ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells
Shougang Zhuang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
A death-promoting role for extracellular signal-regulated kinase
Shougang Zhuang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
COX-2 inhibits anoikis by activation of the PI-3K/Akt pathway in human bladder cancer cells
EM Choi et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2005)
SV40-dependent AKT activity drives mesothelial cell transformation after asbestos exposure
P Cacciotti et al.
CANCER RESEARCH (2005)
p21-mediated nuclear retention of cyclin B1-Cdk1 in response to genotoxic stress
FB Charrier-Savournin et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts:: implications for lung inflammation and cancer
CA Martey et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
The RNA-binding protein HuR regulates the expression of cyclooxygenase-2
S Sengupta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Cyclooxygenase 2: a molecular target for cancer prevention and treatment
K Subbaramaiah et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Post-transcriptional control of cyclooxygenase-2 gene expression -: The role of the 3′-untranslated region
DA Dixon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The p42/p44 MAP kinase pathway prevents apoptosis induced by anchorage and serum removal
M Le Gall et al.
MOLECULAR BIOLOGY OF THE CELL (2000)
分享论文
